JMX-2002

N/A

Report date: 2024/10/16 13:40:51

Base Information

Drug NameJMX-2002
Drug Alias NameJMX-2002JMX2002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Jimincare Shanhe Pharmaceutical Co LtdChangzhou Jinyuan Pharmaceutical Manufacturing Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Jinyuan Pharmaceutical Manufacturing Co LtdWuxi Jimincare Shanhe Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A